Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

SABSSAB Biotherapeutics, Inc.

Nasdaq · CIK 0001833214
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts343

Identity from submissions API

NameSAB Biotherapeutics, Inc.
CIK0001833214
TickersSABS
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN853899721
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone305-845-2813
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Big Cypress Acquisition Corp. (2020-12-07T05:00:00.000Z → 2021-10-22T04:00:00.000Z)
Business address
777 W 41ST ST
SUITE 401
MIAMI BEACH
FL
33140
FL
Mailing address
777 W 41ST ST
SUITE 401
MIAMI BEACH
FL
33140
FL

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

436 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-008061 005-92283 261559168 34 10030
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001213900-26-120155 005-92283 261555526 34 20584
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-005056 005-92283 261555130 34 15936
2026-11-05 10-Q 10-Q 0001193125-26-448600 001-39871 261524830 34 16914122 1 1
2026-10-22 25-NSE xslF25X02/primary_doc.xml 0001354457-26-001016 333-251178 261479111 34 3136
2026-10-13 8-K 8-K 8.01,9.01 0001193125-26-419769 001-39871 261454845 34 244650 1 1
2026-09-18 4 4 0001193125-26-395552 5341
2026-08-21 424B3 424B3 0001193125-26-361180 333-289992 261305094 33 159325
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-352646 005-92283 261283756 34 11005
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001727492-26-000022 005-92283 261283183 34 10143
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001831942-26-000035 005-92283 261281422 34 16125
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001213900-26-090054 005-92283 261281410 34 20570
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-005263 005-92283 261277860 34 10026
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-003437 005-92283 261275848 34 15937
2026-08-12 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-004984 005-92283 261266255 34 15765
2026-08-10 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001346824-26-000220 005-92283 261258838 34 16972
2026-08-06 10-Q 10-Q 0001193125-26-336783 001-39871 261246085 34 15163974 1 1
2026-07-07 8-K 8-K 7.01,9.01 0001193125-26-296936 001-39871 261157857 34 273229 1 1
2026-06-26 4 4 0001193125-26-285722 5341
2026-06-18 8-K 8-K 5.07 0001193125-26-275976 001-39871 261103300 34 209143 1 1
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-226560 005-92283 26986548 34 10894
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001727492-26-000011 005-92283 26984141 34 10097
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-225169 005-92283 26982000 34 142223
2026-05-12 10-Q 10-Q 0001193125-26-218195 001-39871 26965892 34 14591787 1 1
2026-05-04 8-K 8-K 1.01,9.01 0001193125-26-204125 001-39871 26938352 34 567324 1 1
2026-05-01 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-054220 005-92283 26933558 34 16043
2026-04-30 DEF 14A DEF 14A 0001193125-26-197607 001-39871 26926503 34 2265129
2026-04-22 8-K 8-K 7.01,9.01 0001193125-26-168569 001-39871 26881349 34 6011340 1 1
2026-03-31 S-8 S-8 0001193125-26-134733 333-294806 26823796 33 436244 1 1
2026-03-25 4 4 0001193125-26-124231 5340
2026-03-23 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001346824-26-000079 005-92283 26782567 34 19394
2026-03-19 8-K 8-K 1.01,8.01,9.01 0001193125-26-114730 001-39871 26771752 34 1105712 1 1
2026-03-19 424B5 424B5 0001193125-26-114728 333-292482 26771742 33 767980
2026-03-17 424B5 424B5 0001193125-26-110666 333-292482 26761621 33 732109
2026-03-11 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001346824-26-000072 005-92283 26744058 34 17064
2026-03-10 8-K 8-K 7.01,8.01,9.01 0001193125-26-099376 001-39871 26737243 34 15301946 1 1
2026-03-09 10-K 10-K 0001833214-26-000003 001-39871 26736070 34 23199225 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000921895-26-000472 005-92283 26641882 34 27153
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001493215-26-000048 005-92283 26636790 34 10894
2026-02-05 4 4 0001193125-26-039577 5626
2026-02-05 4 4 0001193125-26-039564 5648
2026-02-05 4 4 0001193125-26-039537 5657
2026-02-05 4 4 0001193125-26-039524 5662
2026-02-05 4 4 0001193125-26-039508 5657
2026-01-22 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-26-019535 005-92283 26552168 34 296843
2026-01-12 8-K 8-K 7.01,9.01 0001193125-26-010515 001-39871 26527404 34 14137654 1 1
2026-01-07 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000101 333-292482 26517252 33 1876
2026-01-07 4 4 0001193125-26-006435 5585
2026-01-07 4 4 0001193125-26-006427 5586
2026-01-07 3 3 0001193125-26-006411 7086
2026-01-07 3 3 0001193125-26-006407 6858
2026-01-07 8-K 8-K 5.02,7.01,9.01 0001193125-26-005487 001-39871 26514084 34 268635 1 1
2026-01-05 CORRESP filename1.htm 0001193125-26-002599 17714
2026-01-02 UPLOAD filename1.pdf 0000000000-26-000022 333-292482 40252
2025-12-29 S-3 S-3 0001193125-25-335445 333-292482 251611607 33 2443815 1 1
2025-12-29 8-K 8-K 8.01 0001193125-25-335267 001-39871 251609039 34 190764 1 1
2025-12-18 4 4 0001193125-25-325007 5565
2025-12-18 4 4 0001193125-25-325002 5546
2025-12-18 4 4 0001193125-25-324991 5513
2025-12-18 4 4 0001193125-25-324976 5528
2025-12-18 4 4 0001193125-25-324970 5528
2025-12-18 4 4 0001193125-25-324963 5533
2025-12-15 S-8 S-8 0001193125-25-319278 333-292143 251572021 33 418414 1 1
2025-12-12 4 4 0001193125-25-317688 5192
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000921895-25-003116 005-92283 251486835 34 27019
2025-11-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-005039 005-92283 251486625 34 11562
2025-11-14 10-Q 10-Q 0001193125-25-280572 001-39871 251480045 34 16156646 1 1
2025-11-12 424B3 424B3 0001193125-25-277813 333-289992 251473731 33 187476
2025-10-03 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-25-096128 005-92283 251374388 34 27074
2025-10-03 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001346824-25-000015 005-92283 251374277 34 30286
2025-10-03 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001493152-25-016846 005-92283 251373747 34 24001
2025-10-01 4 4 0001193125-25-226846 8979
2025-10-01 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001012975-25-000592 15486
2025-09-30 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003220 333-289992 251362351 33 1877
2025-09-30 8-K 8-K 5.02,9.01 0001193125-25-225119 001-39871 251360990 34 187861 1 1
2025-09-26 CORRESP filename1.htm 0001193125-25-220723 18477
2025-09-26 8-K 8-K 5.02,5.07,9.01 0001193125-25-220721 001-39871 251351130 34 495561 1 1
2025-09-22 S-3/A S-3/A 0001193125-25-211553 333-289992 251330903 33 617003
2025-09-22 CORRESP filename1.htm 0001193125-25-211554 41237
2025-09-22 4 4 0001193125-25-211490 5192
2025-09-15 UPLOAD filename1.pdf 0000000000-25-009986 333-289992 44021
2025-09-02 S-3 S-3 0001833214-25-000011 333-289992 251286697 33 861372 1 1
2025-08-29 DEF 14A DEF 14A 0001193125-25-192856 001-39871 251282134 34 1840925
2025-08-28 4 4 0000950170-25-112077 5956
2025-08-28 4 4 0000950170-25-112056 5946
2025-08-28 4 4 0000950170-25-112047 5942
2025-08-28 4 4 0000950170-25-112045 5939
2025-08-28 4 4 0000950170-25-112043 5913
2025-08-19 PRE 14A PRE 14A 0001833214-25-000003 001-39871 251232197 34 1608004
2025-08-07 10-Q 10-Q 0000950170-25-104566 001-39871 251191605 34 13158799 1 1
2025-08-05 D xslFormDX01/primary_doc.xml 06b 0000950123-25-007031 021-553778 251186111 33 19259
2025-07-24 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-013136 19336
2025-07-24 4 4 0000950170-25-098365 12945
2025-07-21 8-K 8-K 1.01,3.02,5.03,8.01,9.01 0000950170-25-097078 001-39871 251135716 34 1658743 1 1
2025-07-17 8-K 8-K 5.07 0000950170-25-096645 001-39871 251131323 34 209154 1 1
2025-06-02 DEF 14A DEF 14A 0000950170-25-080361 001-39871 251015915 34 2249984
2025-05-09 10-Q 10-Q 0000950170-25-067554 001-39871 25928524 34 11438365 1 1
2025-04-03 S-8 S-8 0000950170-25-050587 333-286368 25810728 33 275328
2025-04-01 4 4 0000950170-25-048551 5233
2025-03-31 10-K 10-K 0000950170-25-046994 001-39871 25788131 34 19792892 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-020485 005-92283 25623670 34 11224
2025-02-05 8-K 8-K 1.01,2.01,9.01 0000950170-25-014627 001-39871 25594178 34 379230 1 1
2025-01-28 8-K 8-K 8.01,9.01 0000950170-25-009474 001-39871 25560903 34 22552708 1 1
2024-12-31 4 4 0000950170-24-141672 5241
2024-11-06 10-Q 10-Q 0000950170-24-122443 001-39871 241431987 34 11098686 1 1
2024-11-05 4 4 0000950170-24-121563 7855
2024-09-09 8-K 8-K 7.01,9.01 0000950170-24-104564 001-39871 241285904 34 8575778 1 1
2024-08-13 4 4 0000950170-24-096405 5714
2024-08-12 S-8 S-8 0000950170-24-095538 333-281499 241197930 33 481934
2024-08-08 10-Q 10-Q 0000950170-24-094084 001-39871 241188955 34 10952465 1 1
2024-07-31 3 3 0000950170-24-088675 3068
2024-07-31 8-K 8-K 5.02,7.01,9.01 0000950170-24-088247 001-39871 241159931 34 419969 1 1
2024-07-17 4 4 0000950170-24-084294 5537
2024-07-17 4 4 0000950170-24-084293 7858
2024-07-17 4 4 0000950170-24-084299 7869
2024-07-17 4 4 0000950170-24-084292 7888
2024-07-17 4 4 0000950170-24-084291 5494
2024-07-17 4 4 0000950170-24-084290 14926
2024-07-17 4 4 0000950170-24-084296 7844
2024-07-17 4 4 0000950170-24-084295 5659
2024-07-17 4 4 0000950170-24-084288 5509
2024-06-27 8-K 8-K 5.07 0000950170-24-078622 001-39871 241080608 34 211103 1 1
2024-06-24 3 3 0000950170-24-076849 4891
2024-05-31 8-K 8-K 5.02,7.01,9.01 0000950170-24-066856 001-39871 241007082 34 302285 1 1
2024-05-30 DEF 14A DEF 14A 0000950170-24-066767 001-39871 241006572 34 2595803
2024-05-21 8-K 8-K 8.01,9.01 0000950170-24-062656 001-39871 24966836 34 212738 1 1
2024-05-20 10-Q 10-Q 0000950170-24-062367 001-39871 24964301 34 9933413 1 1
2024-05-15 NT 10-Q NT 10-Q 0000950170-24-060524 001-39871 24951443 34 44323
2024-05-14 3 3 0000950170-24-059747 3057
2024-05-08 8-K 8-K 5.02,7.01,9.01 0000950170-24-054868 001-39871 24923630 34 216995 1 1
2024-04-15 8-K 8-K 7.01 0000950170-24-044497 001-39871 24845445 34 204768 1 1
2024-03-29 8-K 8-K 2.02,9.01 0000950170-24-038429 001-39871 24802278 34 3763423 1 1
2024-03-29 10-K 10-K 0000950170-24-038219 001-39871 24800761 34 16374994 1 1
2024-03-08 8-K 8-K 1.01,5.02,9.01 0000950170-24-028666 001-39871 24734840 34 617066 1 1
2024-02-23 4 4 0000950170-24-019460 5600
2024-02-23 4 4 0000950170-24-019441 5567
2024-02-23 4 4 0000950170-24-019434 5595
2024-02-23 4 4 0000950170-24-019432 5568
2024-02-23 4 4 0000950170-24-019430 5611
2024-02-23 S-8 S-8 0000950170-24-019383 333-277314 24671485 33 492773
2024-02-14 SC 13G/A formsc13ga.htm 0001493152-24-006626 005-92283 24637756 34 89549
2024-02-14 SC 13G SAB BIOTHERAPEUTICS, INC. 0000902664-24-001535 005-92283 24632191 34 73573
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-022778 005-92283 24632024 34 147696
2024-02-02 8-K 8-K 5.02,7.01,9.01 0000950170-24-010093 001-39871 24588830 34 208154 1 1
2024-01-26 8-K 8-K 1.01,9.01 0000950170-24-007941 001-39871 24567926 34 639823 1 1
2024-01-26 424B5 424B5 0000950170-24-007904 333-271768 24567663 33 501154
2024-01-25 8-K 8-K 8.01,9.01 0000950170-24-007480 001-39871 24563042 34 202786 1 1
2024-01-19 8-K 8-K 7.01,9.01 0000950170-24-005793 001-39871 24545878 34 14346741 1 1
2024-01-03 8-K 8-K 3.03,5.03,5.07,7.01,9.01 0000950170-24-000543 001-39871 24504483 34 246163 1 1
2023-12-18 DEF 14A DEF 14A 0000950170-23-070950 001-39871 231492444 34 1211103
2023-12-08 PRE 14A PRE 14A 0000950170-23-069098 001-39871 231476418 34 1141345
2023-12-08 4 4 0000950170-23-068922 4621
2023-12-04 SC 13G SCHEDULE 13G 0000921895-23-002708 005-92283 231463697 34 292371
2023-11-30 4 4 0000950170-23-067072 4613
2023-11-30 4 4 0000950170-23-066901 5565
2023-11-29 8-K 8-K 7.01,9.01 0000950170-23-066553 001-39871 231448479 34 227934 1 1
2023-11-28 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-11-28 17:00:00 9999999995-23-003472 333-275319 231448263 33 1817
2023-11-28 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-021502 18847
2023-11-28 4 4 0000950170-23-066395 12693
2023-11-28 4 4 0000950170-23-066394 9158
2023-11-24 CORRESP filename1.htm 0000950170-23-066005 14065
2023-11-22 8-K 8-K 5.03,5.07,9.01 0000950170-23-065895 001-39871 231434063 34 222496 1 1
2023-11-22 3 3 0000950170-23-065888 9677
2023-11-20 8-K 8-K 5.02,7.01,9.01 0000950170-23-065178 001-39871 231423456 34 215963 1 1
2023-11-20 S-3/A S-3/A 0000950170-23-065147 333-275319 231423339 33 476868
2023-11-15 4/A 4/A 0000950170-23-064323 7791
2023-11-15 4/A AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-020902 14474
2023-11-14 4 4 0000950170-23-063918 18110
2023-11-14 DEFA14A DEFA14A 0000950170-23-063776 001-39871 231407068 34 47068
2023-11-14 8-K/A 8-K/A 3.02,8.01,9.01 0000950170-23-063774 001-39871 231407063 34 211994 1 1
2023-11-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-020791 24262
2023-11-13 10-Q 10-Q 0000950170-23-063076 001-39871 231399673 34 10615862 1 1
2023-11-07 UPLOAD filename1.pdf 0000000000-23-012205 40403
2023-11-03 S-3 S-3 0000950170-23-058898 333-275319 231377177 33 637095
2023-11-03 4 4 0000950170-23-058894 5977
2023-11-03 3 3 0000950170-23-058886 3011
2023-10-30 DEF 14A DEF 14A 0000950170-23-056434 001-39871 231361152 34 1313750
2023-10-27 8-K 8-K 1.01,5.02,9.01 0000950170-23-056048 001-39871 231356214 34 410271 1 1
2023-10-24 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-019668 16914
2023-10-24 4 4 0000950170-23-054936 10601
2023-10-20 PRE 14A PRE 14A 0000950170-23-054396 001-39871 231337427 34 353585
2023-10-16 D xslFormDX01/primary_doc.xml 06b 0001209191-23-052843 021-494844 231327428 33 14362
2023-10-16 SC 13G formsc13g.htm 0001493152-23-037345 005-92283 231327387 34 98971
2023-10-10 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-019183 18096
2023-10-10 3 3 0000950170-23-052624 11358
2023-10-02 8-K 8-K 1.01,3.02,5.02,5.03,8.01,9.01 0000950170-23-051127 001-39871 231299713 34 1787963 1 1
2023-09-27 UPLOAD filename1.pdf 0000000000-23-010671 39757
2023-09-26 CORRESP filename1.htm 0000950170-23-049985 36524
2023-09-25 UPLOAD filename1.pdf 0000000000-23-010559 43415
2023-08-30 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-08-30 17:00:00 9999999995-23-002536 333-274119 231226861 33 1817
2023-08-28 CORRESP filename1.htm 0000950170-23-044828 19244
2023-08-28 UPLOAD filename1.pdf 0000000000-23-009436 40333
2023-08-21 S-3 FORM S-3 0001437749-23-024291 333-274119 231189286 33 293196
2023-08-21 8-K 8-K 4.01,9.01 0000950170-23-043561 001-39871 231187396 34 210893 1 1
2023-08-21 10-Q FORM 10-Q 0001437749-23-024224 001-39871 231187394 34 6793769 1 1
2023-08-14 NT 10-Q FORM NT 10-Q 0001437749-23-023658 001-39871 231169674 34 19949
2023-07-31 8-K FORM 8-K 4.01,9.01 0001437749-23-021186 001-39871 231127928 34 189141 1 1
2023-07-31 AW FORM AW 0001437749-23-021177 333-271543 231127763 NE 9731
2023-07-10 POS AM FORM POS AM 0001437749-23-019653 333-271543 231080596 33 300021
2023-07-03 8-K FORM 8-K 5.07 0001437749-23-019198 001-39871 231064457 34 190673 1 1
2023-06-21 RW FORM RW 0001437749-23-017991 333-267012 231029842 NE 8820
2023-06-21 8-K FORM 8-K 7.01,9.01 0001437749-23-017924 001-39871 231027494 34 691881 1 1
2023-06-14 8-K FORM 8-K 7.01,9.01 0001437749-23-017353 001-39871 231013088 34 11243878 1 1
2023-05-19 DEF 14A FORM DEF 14A 0001437749-23-015192 001-39871 23938124 34 836862
2023-05-17 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-05-17 17:00:00 9999999995-23-001464 333-271768 23933616 33 1816
2023-05-15 10-Q FORM 10-Q 0001437749-23-014634 001-39871 23923702 34 6489367 1 1
2023-05-15 CORRESP filename1.htm 0001437749-23-014291 7373
2023-05-12 8-K FORM 8-K 7.01,9.01 0001437749-23-014272 001-39871 23917043 34 4175389 1 1
2023-05-12 UPLOAD filename1.pdf 0000000000-23-005068 40383
2023-05-09 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-05-09 17:00:00 9999999995-23-001353 333-271543 23904119 33 1816
2023-05-09 S-3 FORM S-3 0001437749-23-013303 333-271768 23902163 33 897617
2023-05-05 CORRESP filename1.htm 0001437749-23-012799 7469
2023-05-04 UPLOAD filename1.pdf 0000000000-23-004662 40380
2023-05-01 S-3 FORM S-3 0001437749-23-011878 333-271543 23873662 33 364763
2023-04-28 10-K/A FORM 10-K/A 0001437749-23-011640 001-39871 23867019 34 9508942 1 1
2023-04-28 10-K/A FORM 10-K/A 0001437749-23-011641 001-39871 23867013 34 288108 1 1
2023-04-28 8-K FORM 8-K 7.01,9.01 0001437749-23-011514 001-39871 23860718 34 312741 1 1
2023-04-19 8-K FORM 8-K 7.01,9.01 0001437749-23-010655 001-39871 23830654 34 232738 1 1
2023-04-14 10-K FORM 10-K 0001437749-23-010343 001-39871 23821867 34 18356573 1 1
2023-04-14 8-K FORM 8-K 7.01,9.01 0001437749-23-010220 001-39871 23819883 34 232131 1 1
2023-04-05 4 FORM 4 0001437749-23-009554 5341
2023-04-05 3 FORM 3 0001437749-23-009552 2792
2023-04-04 8-K FORM 8-K 5.02,7.01,9.01 0001437749-23-009184 001-39871 23795410 34 226320 1 1
2023-03-31 NT 10-K FORM NT 10-K 0001437749-23-008874 001-39871 23789105 34 23948
2023-03-31 8-K FORM 8-K 2.02,4.02 0001437749-23-008871 001-39871 23789094 34 228624 1 1
2023-03-24 8-K FORM 8-K 2.03,3.02 0001437749-23-007867 001-39871 23760826 34 185851 1 1
2023-03-16 4 FORM 4 0001437749-23-006913 4823
2023-03-16 4 FORM 4 0001437749-23-006911 5362
2023-03-16 4 FORM 4 0001437749-23-006910 5381
2023-03-16 4 FORM 4 0001437749-23-006909 5335
2023-03-16 4 FORM 4 0001437749-23-006908 5312
2023-03-07 424B3 FORM 424B3 0001437749-23-005686 333-269565 23713492 33 363950
2023-03-02 4 FORM 4 0001437749-23-005167 5195
2023-03-02 4 FORM 4 0001437749-23-005165 8090
2023-02-10 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-02-10 17:00:00 9999999995-23-000384 333-269565 23614386 33 1816
2023-02-10 5 SABS_CHAMILTON_FORM5_2022FYE 0001437749-23-003040 7152
2023-02-08 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001437749-23-002488,2023-02-08 9999999995-23-000316 333-261496 23600923 33 1829
2023-02-08 CORRESP filename1.htm 0001437749-23-002806 7288
2023-02-08 UPLOAD filename1.pdf 0000000000-23-001308 40295
2023-02-07 8-K FORM 8-K 7.01,9.01 0001437749-23-002624 001-39871 23592973 34 1653958 1 1
2023-02-03 S-3 FORM S-3 0001437749-23-002490 333-269565 23586909 33 473576
2023-02-03 POS AM FORM POS AM 0001437749-23-002488 333-261496 23586886 33 313664
2023-01-27 8-K FORM 8-K 3.01 0001437749-23-001990 001-39871 23563686 34 184104 1 1
2023-01-10 8-K 8-K 7.01,9.01 0000950170-23-000576 001-39871 23519781 34 250490 1 1
2023-01-09 8-K 8-K 7.01,9.01 0000950170-23-000472 001-39871 23516835 34 11010200 1 1
2023-01-05 8-K 8-K 7.01,9.01 0000950170-23-000243 001-39871 23511652 34 250723 1 1
2022-12-16 SC 13D/A SC 13D/A 0000950170-22-026678 005-92283 221468420 34 162280
2022-12-12 8-K 8-K 1.01,3.02,8.01,9.01 0000950170-22-026346 001-39871 221456337 34 1120139 1 1
2022-12-09 4 FORM 4 SUBMISSION 0001209191-22-060501 9573
2022-12-09 4 FORM 4 SUBMISSION 0001209191-22-060442 7526
2022-12-09 4 FORM 4 SUBMISSION 0001209191-22-060440 7778
2022-11-21 8-K 8-K 7.01,8.01,9.01 0000950170-22-025544 001-39871 221406324 34 4178412 1 1
2022-11-18 424B3 424B3 0000950170-22-025415 333-261496 221400705 33 2811199
2022-11-14 10-Q 10-Q 0000950170-22-025094 001-39871 221387965 34 11377031 1 1
2022-11-07 8-K 8-K 7.01,8.01,9.01 0000950170-22-022367 001-39871 221364048 34 5400955 1 1
2022-11-01 8-K 8-K 1.01,8.01,9.01 0000950170-22-020881 001-39871 221351347 34 426823 1 1
2022-10-13 8-K 8-K 1.01,2.03,9.01 0000950170-22-019554 001-39871 221309690 34 668210 1 1
2022-10-07 8-K 8-K 3.01 0000950170-22-019398 001-39871 221301423 34 207249 1 1
2022-09-30 8-K 8-K 7.01,9.01 0000950170-22-019082 001-39871 221282463 34 473202 1 1
2022-09-28 8-K 8-K 7.01,8.01,9.01 0000950170-22-018944 001-39871 221272881 34 2001429 1 1
2022-09-23 8-K 8-K 7.01,8.01,9.01 0000950170-22-018805 001-39871 221260692 34 3881551 1 1
2022-09-15 4 FORM 4 SUBMISSION 0001209191-22-050106 5720
2022-09-15 4 FORM 4 SUBMISSION 0001209191-22-050105 5698
2022-09-15 4 FORM 4 SUBMISSION 0001209191-22-050094 5701
2022-09-15 4 FORM 4 SUBMISSION 0001209191-22-050093 5718
2022-09-15 4 FORM 4 SUBMISSION 0001209191-22-050082 5722
2022-09-15 4 FORM 4 SUBMISSION 0001209191-22-050081 5690
2022-09-14 4 FORM 4 SUBMISSION 0001209191-22-049950 5163
2022-09-08 SC 13D/A SC 13D/A 0000950170-22-018255 005-92283 221234427 34 103721
2022-09-08 SC 13D/A SC 13D/A 0000950170-22-018253 005-92283 221234398 34 160997
2022-09-08 4 FORM 4 SUBMISSION 0001209191-22-049168 4594
2022-08-23 S-1 S-1 0001193125-22-226637 333-267012 221184790 33 20766342 1 1
2022-08-17 424B3 424B3 0000950170-22-017558 333-261496 221175410 33 2521836
2022-08-10 10-Q 10-Q 0000950170-22-016221 001-39871 221150139 34 10630939 1 1
2022-07-13 3 FORM 3 SUBMISSION 0001209191-22-042071 2985
2022-07-11 8-K 8-K 5.07,7.01,8.01,9.01 0000950170-22-012572 001-39871 221075992 34 3435312 1 1
2022-07-05 8-K 8-K 7.01,9.01 0000950170-22-012460 001-39871 221065403 34 3357011 1 1
2022-06-07 4 FORM 4 SUBMISSION 0001209191-22-034919 5239
2022-06-07 3 FORM 3 SUBMISSION 0001209191-22-034905 3063
2022-06-07 8-K 8-K 7.01,9.01 0000950170-22-011250 001-39871 22999840 34 2105606 1 1
2022-06-07 424B3 424B3 0000950170-22-011238 333-261496 22999381 33 149994
2022-06-06 8-K 8-K 8.01,9.01 0000950170-22-011205 001-39871 22997472 34 252909 1 1
2022-05-27 SC 13D/A SC 13D/A 0001193125-22-162385 005-92283 22977958 34 48446
2022-05-25 DEF 14A DEF 14A 0000950170-22-010672 001-39871 22963899 34 2212546
2022-05-23 4 FORM 4 SUBMISSION 0001209191-22-031401 5215
2022-05-23 4 FORM 4 SUBMISSION 0001209191-22-031398 7349
2022-05-16 424B3 424B3 0000950170-22-009899 333-261496 22924553 33 1944233
2022-05-12 10-Q 10-Q 0000950170-22-009722 001-39871 22918442 34 9732867 1 1
2022-04-29 424B3 424B3 0001193125-22-133785 333-261496 22875665 33 4691548
2022-04-26 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-22-111227,2022-04-26 9999999995-22-001086 333-261496 22856104 33 1829
2022-04-20 POS AM POS AM 0001193125-22-111227 333-261496 22838748 33 14163191 1 1
2022-03-29 10-K 10-K 0000950170-22-004935 001-39871 22781601 34 54114486 1 1
2022-03-18 4 FORM 4 SUBMISSION 0000899243-22-011667 5644
2022-03-18 4 FORM 4 SUBMISSION 0000899243-22-011666 5630
2022-03-18 4 FORM 4 SUBMISSION 0000899243-22-011665 5645
2022-03-18 4 FORM 4 SUBMISSION 0000899243-22-011664 5674
2022-03-18 4 FORM 4 SUBMISSION 0000899243-22-011663 5660
2022-03-18 4 FORM 4 SUBMISSION 0000899243-22-011662 5658
2022-03-18 4 FORM 4 SUBMISSION 0000899243-22-011661 5642
2022-03-18 4 FORM 4 SUBMISSION 0000899243-22-011660 5663
2022-03-18 4 FORM 4 SUBMISSION 0000899243-22-011659 5647
2022-02-14 SC 13G/A SC 13G/A 0001104659-22-021075 005-92283 22624524 34 122890
2022-02-11 SC 13G/A SC 13G/A 0001140361-22-004820 005-92283 22620248 34 178155
2022-02-01 S-8 S-8 0001193125-22-024568 333-262452 22578850 33 116000
2022-01-10 8-K form8-k.htm 7.01 0001493152-22-000737 001-39871 22519517 34 259586 1 1
2022-01-06 8-K form8-k.htm 5.02 0001493152-22-000588 001-39871 22515495 34 260963 1 1
2021-12-29 424B3 424B3 0001193125-21-369110 333-261496 211528826 33 5836769
2021-12-15 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2021-12-15 16:00:00 9999999995-21-004712 333-261496 211495869 33 1847
2021-12-13 CORRESP filename1.htm 0001193125-21-354834 8408
2021-12-08 UPLOAD filename1.pdf 0000000000-21-014743 40295
2021-12-03 S-1 forms-1.htm 0001493152-21-030474 333-261496 211471021 33 15581029 1 1
2021-11-24 4/A xslF345X03/ownership.xml 0001493152-21-029889 12701
2021-11-22 8-K/A form8-ka.htm 9.01 0001493152-21-029557 001-39871 211432542 34 1097724 1 1
2021-11-22 10-Q form10-q.htm 0001493152-21-029551 001-39871 211432483 34 3748978 1 1
2021-11-22 4/A xslF345X03/ownership.xml 0001493152-21-029528 10689
2021-11-22 8-K form8k.htm 2.02,4.02,9.01 0001493152-21-029460 001-39871 211430170 34 339867 1 1
2021-11-19 8-K form8-k.htm 1.01,5.02,9.01 0001493152-21-029397 001-39871 211428956 34 426887 1 1
2021-11-19 4 xslF345X03/ownership.xml 0001493152-21-029395 5696
2021-11-19 4 xslF345X03/ownership.xml 0001493152-21-029370 5724
2021-11-16 4 xslF345X03/ownership.xml 0001493152-21-028917 13631
2021-11-15 NT 10-Q formnt10q.htm 0001493152-21-028684 001-39871 211411849 34 37119
2021-11-02 SC 13D sc-13d.htm 0001493152-21-026918 005-92283 211368774 34 110747
2021-11-01 SC 13D sc13d.htm 0001493152-21-026891 005-92283 211367972 34 99310
2021-11-01 SC 13D sc13d.htm 0001493152-21-026888 005-92283 211367946 34 62179
2021-10-28 8-K form8-k.htm 1.01,2.01,3.02,4.01,5.01,5.02,5.03,5.06,9.01 0001493152-21-026649 001-39871 211359463 34 40244849 1 1
2021-10-26 4 xslF345X03/ownership.xml 0001493152-21-026394 6635
2021-10-26 4 xslF345X03/ownership.xml 0001493152-21-026393 6649
2021-10-26 4 xslF345X03/ownership.xml 0001493152-21-026392 16827
2021-10-26 4 xslF345X03/ownership.xml 0001493152-21-026391 10079
2021-10-26 4 xslF345X03/ownership.xml 0001493152-21-026390 16755
2021-10-26 4 xslF345X03/ownership.xml 0001493152-21-026389 50238
2021-10-26 4 xslF345X03/ownership.xml 0001493152-21-026388 18166
2021-10-26 4 xslF345X03/ownership.xml 0001493152-21-026387 22899
2021-10-26 4 xslF345X03/ownership.xml 0001493152-21-026386 10399
2021-10-26 4 xslF345X03/ownership.xml 0001493152-21-026385 21857
2021-10-26 4 xslF345X03/ownership.xml 0001493152-21-026384 16769
2021-10-26 4 xslF345X03/ownership.xml 0001493152-21-026383 15504
2021-10-26 4 xslF345X03/ownership.xml 0001493152-21-026382 50725
2021-10-26 4 xslF345X03/ownership.xml 0001493152-21-026380 14525
2021-10-26 4 xslF345X03/ownership.xml 0001493152-21-026379 16764
2021-10-26 3 xslF345X02/ownership.xml 0001493152-21-026362 2968
2021-10-22 3 xslF345X02/ownership.xml 0001493152-21-026155 2931
2021-10-22 3 xslF345X02/ownership.xml 0001493152-21-026154 4177
2021-10-22 3 xslF345X02/ownership.xml 0001493152-21-026153 2914
2021-10-22 3 xslF345X02/ownership.xml 0001493152-21-026152 2887
2021-10-22 3 xslF345X02/ownership.xml 0001493152-21-026151 5334
2021-10-22 3 xslF345X02/ownership.xml 0001493152-21-026150 2902
2021-10-22 3 xslF345X02/ownership.xml 0001493152-21-026149 2871
2021-10-22 3 xslF345X02/ownership.xml 0001493152-21-026148 2897
2021-10-22 3 xslF345X02/ownership.xml 0001493152-21-026147 2880
2021-10-22 3 xslF345X02/ownership.xml 0001493152-21-026146 3514
2021-10-22 3 xslF345X02/ownership.xml 0001493152-21-026144 3513
2021-10-22 3 xslF345X02/ownership.xml 0001493152-21-026142 3504
2021-10-22 3 xslF345X02/ownership.xml 0001493152-21-026141 2866
2021-10-22 3 xslF345X02/ownership.xml 0001493152-21-026140 2892
2021-10-22 3 xslF345X02/ownership.xml 0001493152-21-026138 2908
2021-10-22 25-NSE xslF25X02/primary_doc.xml 0001354457-21-001207 001-39871 211340745 34 2953
2021-10-21 8-K form8-k.htm 5.07 0001493152-21-025933 001-39871 211335732 34 325809 1 1
2021-10-19 SC 13G BIG CYPRESS ACQUISITION CORP. 0001104659-21-127418 005-92283 211329813 34 126591
2021-10-15 4 xslF345X03/ownership.xml 0001493152-21-025510 6285
2021-10-15 4 xslF345X03/ownership.xml 0001493152-21-025508 6402
2021-10-13 425 form8-k.htm 0001493152-21-025288 001-39871 211320736 34 43541
2021-10-13 8-K form8-k.htm 8.01 0001493152-21-025286 001-39871 211320729 34 286694 1 1
2021-10-12 425 form8-k.htm 0001493152-21-025138 001-39871 211317183 34 127520
2021-10-12 8-K form8-k.htm 1.01,9.01 0001493152-21-025137 001-39871 211317181 34 394267 1 1
2021-10-07 425 form425.htm 0001493152-21-024890 001-39871 211311231 34 69923
2021-10-05 4 xslF345X03/ownership.xml 0001493152-21-024641 4692
2021-10-05 4 xslF345X03/ownership.xml 0001493152-21-024640 6287
2021-10-04 425 form425.htm 0001493152-21-024531 001-39871 211303907 34 106389
2021-09-28 425 form425.htm 0001493152-21-023933 001-39871 211283935 34 148501
2021-09-27 425 form425.htm 0001493152-21-023691 001-39871 211278903 34 122173
2021-09-24 424B3 form424b3.htm 0001493152-21-023619 333-258869 211278060 33 8445151
2021-09-23 424B3 form424b3.htm 0001493152-21-023492 333-258869 211272930 33 9864598
2021-09-22 EFFECT xslEFFECTX01/primary_doc.xml S-4,,2021-09-22 16:30:00 9999999995-21-003620 333-258869 211270893 33 1749
2021-09-22 425 form425.htm 0001493152-21-023397 001-39871 211270275 34 65396
2021-09-22 CORRESP filename1.htm 0001493152-21-023332 11506
2021-09-22 S-4/A forms-4a.htm 0001493152-21-023292 333-258869 211267410 33 16065473 1 1
2021-09-21 CORRESP filename1.htm 0001493152-21-023246 10468
2021-09-16 CORRESP filename1.htm 0001493152-21-022881 11077
2021-09-08 425 form425.htm 0001493152-21-022215 001-39871 211242764 34 37291
2021-09-08 CORRESP filename1.htm 0001493152-21-022197 31227
2021-09-08 S-4/A forms-4a.htm 0001493152-21-022195 333-258869 211241731 33 16583881 1 1
2021-09-07 425 form425.htm 0001493152-21-022074 001-39871 211238556 34 628434
2021-09-02 UPLOAD filename1.pdf 0000000000-21-010747 47926
2021-08-17 CORRESP filename1.htm 0001493152-21-020335 183956
2021-08-17 S-4 forms-4.htm 0001493152-21-020329 333-258869 211180812 33 17335268 1 1
2021-08-16 425 form8-k.htm 0001493152-21-019845 001-39871 211173962 34 209228
2021-08-16 8-K form8-k.htm 1.01,7.01,9.01 0001493152-21-019840 001-39871 211173939 34 492200 1 1
2021-08-12 425 form425.htm 0001493152-21-019430 001-39871 211165397 34 187879
2021-08-09 10-Q form10-q.htm 0001493152-21-019063 001-39871 211157408 34 3248416 1 1
2021-07-29 UPLOAD filename1.pdf 0000000000-21-009347 80836
2021-07-21 425 form425.htm 0001493152-21-017375 001-39871 211102714 34 117726
2021-07-16 425 form425.htm 0001493152-21-016970 001-39871 211093895 34 45230
2021-07-13 425 form425.htm 0001493152-21-016667 001-39871 211086729 34 114772
2021-07-12 425 form425.htm 0001493152-21-016578 001-39871 211084068 34 23254
2021-07-09 425 form425.htm 0001493152-21-016492 001-39871 211081599 34 49592
2021-07-08 425 form425.htm 0001493152-21-016425 001-39871 211079063 34 50860
2021-07-08 425 form425.htm 0001493152-21-016399 001-39871 211078560 34 37535
2021-07-08 425 form425.htm 0001493152-21-016397 001-39871 211078543 34 30837
2021-07-06 425 form425.htm 0001493152-21-016119 001-39871 211072053 34 108982

Latest XBRL company facts

One latest value per concept from companyfacts (343 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 90.09M 2026-11-02 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
dei EntityPublicFloat Entity Public Float USD 76.73M 2025-06-30 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap AccountsPayableAndOtherAccruedLiabilitiesCurrent Accounts Payable and Other Accrued Liabilities, Current USD 11.80M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 2.42M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap AccountsReceivableNet Accounts Receivable, after Allowance for Credit Loss USD 12.94M 2022-09-30 2022 Q3 10-Q 2022-11-14 0000950170-22-025094
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 0 2023-12-31 2023 FY 10-K 2024-03-29 0000950170-24-038219
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD -10,075 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-12 0001193125-26-218195
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 92,281 2022-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009722
us-gaap AccruedInvestmentIncomeReceivable Accrued Investment Income Receivable USD 1.50M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 322,376 2021-09-30 2021 Q3 10-Q 2021-11-22 0001493152-21-029551
us-gaap AccruedPayrollTaxesCurrent Accrued Payroll Taxes, Current USD 412,943 2023-12-31 2023 FY 10-K 2024-03-29 0000950170-24-038219
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 174,554 2023-12-31 2023 FY 10-K 2024-03-29 0000950170-24-038219
us-gaap AccruedVacationCurrent Accrued Vacation, Current USD 656,132 2023-12-31 2023 FY 10-K 2024-03-29 0000950170-24-038219
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 19.50M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -2.30M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap AcquisitionCosts Acquisition Costs, Period Cost USD 5,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-20 0000950170-24-062367
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 393.29M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Decrease for Tax Withholding Obligation USD 5,000 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 7.44M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 3.83M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0000950170-25-046994
us-gaap AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net USD 897,600 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009722
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 20.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 0 2023-12-31 2023 FY 10-K 2024-03-29 0000950170-24-038219
us-gaap AllowanceForDoubtfulAccountsReceivableWriteOffs Accounts Receivable, Allowance for Credit Loss, Writeoff USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-29 0000950170-24-038219
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 204.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap AreaOfRealEstateProperty Area of Real Estate Property sqft 3,099 2025-09-30 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap Assets Assets USD 235.64M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap AssetsCurrent Assets, Current USD 107.74M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap AssetsHeldInTrustNoncurrent Assets Held-in-trust, Noncurrent USD 116.16M 2021-09-30 2021 Q3 10-Q 2021-11-22 0001493152-21-029551
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 178.02M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 103.54M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 101.29M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One USD 74.48M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 74.24M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 175.53M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets USD 35.74M 2021-10-22 2021 FY 10-K/A 2023-04-28 0001437749-23-011640
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities USD 24.84M 2021-10-22 2021 FY 10-K/A 2023-04-28 0001437749-23-011640
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net USD 10.90M 2021-10-22 2021 FY 10-K/A 2023-04-28 0001437749-23-011640
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets USD 102,742 2021-10-22 2021 FY 10-K/A 2023-04-28 0001437749-23-011640
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 682,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap CapitalUnitsAuthorized Capital Units, Authorized shares 810.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap Cash Cash USD 667,873 2021-09-30 2021 Q3 10-Q 2021-11-22 0001493152-21-029551
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 14.44M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 39.55M 2021-12-31 2021 FY 10-K/A 2023-04-28 0001437749-23-011640
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 14.44M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 3.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 0 2021-09-30 2021 Q3 10-Q 2021-11-22 0001493152-21-029551
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2021-09-30 2021 Q3 10-Q 2021-11-22 0001493152-21-029551
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0.01 2021-01-14 2021 Q3 10-Q 2021-11-22 0001493152-21-029551
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 2.75M 2026-03-31 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 12.88M 2023-06-30 2023 Q2 10-Q 2023-08-21 0001437749-23-024224
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 800.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 91.19M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 91.14M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap CommonStockValue Common Stock, Value, Issued USD 9,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -66.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap ConstructionInProgressGross Construction in Progress, Gross USD 404,976 2022-09-30 2022 Q3 10-Q 2022-11-14 0000950170-22-025094
us-gaap ConvertibleDebtNoncurrent Convertible Debt, Noncurrent USD 541,644 2023-06-30 2023 Q2 10-Q 2023-08-21 0001437749-23-024224
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 1 2021-10-01 2023 Q2 10-Q 2023-08-21 0001437749-23-024224
us-gaap DebtInstrumentPeriodicPayment Debt Instrument, Periodic Payment USD 440 2017-11-14 2017-11-15 2021 FY 10-K 2022-03-29 0000950170-22-004935
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-14 0001437749-23-010343
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLoss Debt Securities, Available-for-sale, Allowance for Credit Loss USD 0 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions Security 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 175.41M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss USD 2.49M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions Security 128 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap DebtSecuritiesAvailableForSaleRealizedGain Debt Securities, Available-for-sale, Realized Gain USD 50,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap DebtSecuritiesAvailableForSaleRealizedGainLoss Debt Securities, Available-for-sale, Realized Gain (Loss) USD 47,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap DebtSecuritiesAvailableForSaleRealizedLoss Debt Securities, Available-for-sale, Realized Loss USD 3,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 175.41M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss USD 2.49M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions Security 128 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap DebtSecuritiesRealizedGainLoss Debt Securities, Realized Gain (Loss) USD 47,089 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-12 0001193125-26-218195
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 235,111 2020-12-31 2021 Q3 10-Q 2021-11-22 0001493152-21-029551
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap DeferredIncomeCurrent Deferred Income, Current USD 0 2024-12-31 2024 FY 10-K 2025-03-31 0000950170-25-046994
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 1.71M 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 14.02M 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 38.58M 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2021-12-31 2021 FY 10-K/A 2023-04-28 0001437749-23-011640
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 1.71M 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 19.13M 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 1.40M 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Compensated Absences USD 99,300 2021-12-31 2021 FY 10-K/A 2023-04-28 0001437749-23-011640
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 4.03M 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 1.12M 2021-12-31 2021 FY 10-K/A 2023-04-28 0001437749-23-011640
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 36.87M 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 551,934 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 1.16M 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 1 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-12 0001193125-26-218195
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount Defined Contribution Plan, Maximum Annual Contributions Per Employee, Amount USD 200 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-12 0001193125-26-218195
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 0.03 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-12 0001193125-26-218195
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 2.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD 3.44M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-21 0001493152-21-012524
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 5.58M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.84 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.63 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-29 0000950170-22-004935
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.84 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 0.671 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount USD -672,864 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent pure -0.051 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap EffectiveIncomeTaxRateReconciliationDeductions Effective Income Tax Rate Reconciliation, Deduction, Percent pure 0.21 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-29 0000950170-22-004935
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0.003 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure -0.06 2021-01-01 2021-12-31 2021 FY 10-K/A 2023-04-28 0001437749-23-011640
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.029 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 246,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 5.12M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 87.40M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap EquitySecuritiesFvNi Equity Securities, FV-NI USD 15.40M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap EquitySecuritiesFvNiGainLoss Equity Securities, FV-NI, Gain (Loss) USD -9,587 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-12 0001193125-26-218195
us-gaap EquitySecuritiesFvNiRealizedGain Equity Securities, FV-NI, Realized Gain USD 8,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-09 0000950170-25-067554
us-gaap EquitySecuritiesFvNiRealizedGainLoss Equity Securities, FV-NI, Realized Gain (Loss) USD -20,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap EquitySecuritiesFvNiRealizedLoss Equity Securities, FV-NI, Realized Loss USD 26,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0000950170-25-046994
us-gaap EquitySecuritiesFvNiUnrealizedGain Equity Securities, FV-NI, Unrealized Gain USD 7,000 2024-01-01 2024-03-31 2025 Q1 10-Q 2025-05-09 0000950170-25-067554
us-gaap EquitySecuritiesFvNiUnrealizedGainLoss Equity Securities, FV-NI, Unrealized Gain (Loss) USD 12,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap EquitySecuritiesFvNiUnrealizedLoss Equity Securities, FV-NI, Unrealized Loss USD 7,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-09 0000950170-25-067554
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD -58,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 186,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 3.16M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 163,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 3.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 4.88M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap FinanceLeaseLiabilityPaymentsDueAfterYearFive Finance Lease, Liability, to be Paid, after Year Five USD 3.18M 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 401,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap FinanceLeaseLiabilityPaymentsDueYearFive Finance Lease, Liability, to be Paid, Year Five USD 401,496 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap FinanceLeaseLiabilityPaymentsDueYearFour Finance Lease, Liability, to be Paid, Year Four USD 401,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 401,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 401,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 100,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 1.72M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 37,388 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-12 0001193125-26-218195
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 3.43M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization USD 65,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0.077 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 66,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap GainLossOnTerminationOfLease Gain (Loss) on Termination of Lease USD 7,042 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-12 0001193125-26-218195
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 665,596 2021-01-01 2021-12-31 2021 FY 10-K/A 2023-04-28 0001437749-23-011640
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 21.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD 16.48M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD 13.27M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -3.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap IncomeTaxesPaid Income Taxes Paid USD 25,629 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-29 0000950170-24-038219
us-gaap IncomeTaxExaminationInterestExpense Income Tax Examination, Interest Expense USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-29 0000950170-22-004935
us-gaap IncomeTaxExaminationPenaltiesExpense Income Tax Examination, Penalties Expense USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-29 0000950170-22-004935
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 8.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD 2.79M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 38,487 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD 1.03M 2021-01-01 2021-12-31 2021 FY 10-K/A 2023-04-28 0001437749-23-011640
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 382,211 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -1.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -5.56M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0000950170-25-046994
us-gaap IncreaseDecreaseInAccruedIncomeTaxesPayable Increase (Decrease) in Income Taxes Payable USD 92,281 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009722
us-gaap IncreaseDecreaseInAccruedInterestReceivableNet Increase (Decrease) in Accrued Interest Receivable, Net USD 557,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 251,154 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-22 0001493152-21-029551
us-gaap IncreaseDecreaseInAccruedTaxesPayable Increase (Decrease) in Accrued Taxes Payable USD 0 2022-01-01 2022-09-30 2022 FY 10-K 2023-04-14 0001437749-23-010343
us-gaap IncreaseDecreaseInDeferredIncomeTaxes Increase (Decrease) in Deferred Income Taxes USD -1.32M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-29 0000950170-24-038219
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -1.32M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap IncreaseDecreaseInDueToRelatedParties Increase (Decrease) in Due to Related Parties USD -2,367 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-29 0000950170-24-038219
us-gaap IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable USD 0 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-15 0001437749-23-014634
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -890,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 523,610 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-29 0000950170-24-038219
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 2.70M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009722
us-gaap InterestExpense Interest Expense USD 169,490 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-08 0000950170-24-094084
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 125,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001193125-26-336783
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 4.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap InterestIncomeOther Interest Income, Other USD 2.76M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001193125-26-336783
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 187,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap InterestPayableCurrent Interest Payable, Current USD 21,000 2026-06-30 2026 Q2 10-Q 2026-08-06 0001193125-26-336783
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 3.88M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0000950170-25-046994
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 2.27M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 0 2023-06-30 2023 Q2 10-Q 2023-08-21 0001437749-23-024224
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 613,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 57,761 2024-12-31 2024 FY 10-K 2025-03-31 0000950170-25-046994
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 210,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 642,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 627,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 181,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 516,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap Liabilities Liabilities USD 24.72M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 235.64M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap LiabilitiesCurrent Liabilities, Current USD 14.80M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap LoansPayableToBank Loans Payable to Bank USD 18,997 2017-11-15 2021 FY 10-K 2022-03-29 0000950170-22-004935
us-gaap LongTermInvestments Long-term Investments USD 101.29M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 0 2024-12-31 2024 FY 10-K 2025-03-31 0000950170-25-046994
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 105.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -64.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -37.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -63.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -63.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -63.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 Noncash or Part Noncash Acquisition, Fixed Assets Acquired USD 78,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 5.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap NotesPayable Notes Payable USD 275,849 2024-12-31 2024 FY 10-K 2025-03-31 0000950170-25-046994
us-gaap NotesPayableCurrent Notes Payable, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 150,000 2020-12-31 2021 Q3 10-Q 2021-11-22 0001493152-21-029551
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap OperatingExpenses Operating Expenses USD 69.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -69.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap OperatingLeaseCost Operating Lease, Cost USD 794,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 1.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 1.76M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 407,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 1.35M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap OperatingLeasePayments Operating Lease, Payments USD 766,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 1.72M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.153 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 1.62M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToNoncontrollingInterest Other Comprehensive Income (Loss), Available-for-sale Securities, Tax, Portion Attributable to Noncontrolling Interest USD -546,791 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-12 0001193125-26-218195
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax USD 188,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD 41,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax USD 47,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax USD 47,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-12 0001193125-26-218195
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax USD -2.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD -204,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 1.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 5,488 2021-01-01 2021-12-31 2021 FY 10-K/A 2023-04-28 0001437749-23-011640
us-gaap PaymentsForProceedsFromInvestments Payments for (Proceeds from) Investments USD 116.15M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-22 0001493152-21-029551
us-gaap PaymentsForSecuritiesPurchasedUnderAgreementsToResell Payments for Securities Purchased under Agreements to Resell USD 817,060 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0000950170-22-025094
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 300,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-29 0000950170-24-038219
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 9,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001193125-26-336783
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 159.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 3.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap PreferredStockConvertibleConversionRatio PreferredStockConvertibleConversionRatio pure 0.465 2021-10-01 2023 Q2 10-Q 2023-08-21 0001437749-23-024224
us-gaap PreferredStockConvertibleSharesIssuable PreferredStockConvertibleSharesIssuable shares 8.26M 2021-10-22 2021 FY 10-K/A 2023-04-28 0001437749-23-011640
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2025-06-30 2025 Q2 10-Q 2025-08-07 0000950170-25-104566
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 42,019 2025-06-30 2025 Q2 10-Q 2025-08-07 0000950170-25-104566
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 42,019 2025-06-30 2025 Q2 10-Q 2025-08-07 0000950170-25-104566
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 5 2025-06-30 2025 Q2 10-Q 2025-08-07 0000950170-25-104566
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 2.19M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 867,604 2023-06-30 2023 Q2 10-Q 2023-08-21 0001437749-23-024224
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 116.15M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-22 0001493152-21-029551
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 7.68M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-29 0000950170-24-038219
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 150,000 2021-01-10 2021-01-14 2021 Q3 10-Q 2021-11-22 0001493152-21-029551
us-gaap ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants USD 7.50M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0000950170-25-046994
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 4.17M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-22 0001493152-21-029551
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 6.78M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-22 0001493152-21-029551
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 515,986 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 99.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 20,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets Proceeds from Sales of Business, Affiliate and Productive Assets USD 34.34M 2021-01-01 2021-12-31 2021 FY 10-K/A 2023-04-28 0001437749-23-011640
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 155,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001193125-26-336783
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 16.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 35.15M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 15.65M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap ReclassificationsOfTemporaryToPermanentEquity Reclassifications of Temporary to Permanent Equity USD 16.04M 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap RedeemableNoncontrollingInterestEquityRedemptionValue Redeemable Noncontrolling Interest, Equity, Redemption Value USD 116.15M 2021-06-30 2021 Q3 10-Q 2021-11-22 0001493152-21-029551
us-gaap RelatedPartyTransactionDueFromToRelatedParty Related Party Transaction, Due from (to) Related Party USD 6,250 2021-12-31 2021 FY 10-K 2022-03-29 0000950170-22-004935
us-gaap RelatedPartyTransactionPurchasesFromRelatedParty Related Party Transaction, Purchases from Related Party USD 19,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-29 0000950170-22-004935
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 275,849 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 5.52M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-29 0000950170-24-038219
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 47.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap RestrictedCash Restricted Cash USD 6.34M 2021-12-31 2021 FY 10-K/A 2023-04-28 0001437749-23-011640
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 6.34M 2021-12-31 2021 FY 10-K/A 2023-04-28 0001437749-23-011640
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -174.56M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap Revenues Revenues USD 666,619 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-21 0001437749-23-024224
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 775,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap SecuritiesPurchasedUnderAgreementsToResellLiability Securities Purchased under Agreements to Resell, Liability USD 6.34M 2021-12-31 2021 FY 10-K/A 2023-04-28 0001437749-23-011640
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 20.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested USD 4.10M 2021-12-31 2021 FY 10-K/A 2023-04-28 0001437749-23-011640
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2021-01-01 2021-12-31 2021 FY 10-K/A 2023-04-28 0001437749-23-011640
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.007 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 1.244 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 1.039 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.044 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.044 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.038 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate pure 1.016 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 2.01 2023-06-30 2023 Q2 10-Q 2023-08-21 0001437749-23-024224
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 17,867 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 0 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-29 0000950170-22-004935
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 584,797 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 20.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 3.56 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 1.38M 2021-12-31 2021 FY 10-K/A 2023-04-28 0001437749-23-011640
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value USD/shares 2.17 2021-01-01 2021-12-31 2021 FY 10-K/A 2023-04-28 0001437749-23-011640
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 2.3 2021-12-31 2021 FY 10-K/A 2023-04-28 0001437749-23-011640
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 16.30M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 40.49M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 3.64 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 4.55M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 6.24M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 9.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 4.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 2.42 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 8.51 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 3.56 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 4.37 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap SharePrice Share Price USD/shares 0.7 2022-09-30 2022 Q3 10-Q 2022-11-14 0000950170-22-025094
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 0.012 2020-11-20 2020 FY 10-K 2021-04-02 0001493152-21-007884
us-gaap ShortTermInvestments Short-term Investments USD 89.61M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 100,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 210.92M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.1 2024-01-05 2025 Q2 10-Q 2025-08-07 0000950170-25-104566
us-gaap StockIssued1 Stock Issued USD 116.15M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-22 0001493152-21-029551
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 2.16M 2020-11-18 2020-11-20 2020 FY 10-K 2021-04-02 0001493152-21-007884
us-gaap StockIssuedDuringPeriodSharesShareBasedCompensationForfeited Shares Issued, Shares, Share-based Payment Arrangement, Forfeited shares 375,000 2020-11-12 2020-12-31 2020 FY 10-K 2021-04-02 0001493152-21-007884
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 64,083 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 7.60M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-29 0000950170-22-004935
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 261,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD -5,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 1,150 2021-01-01 2021-03-31 2021 Q3 10-Q 2021-11-22 0001493152-21-029551
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures Stock Issued During Period, Value, Restricted Stock Award, Forfeitures USD 1,049 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-29 0000950170-22-004935
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 1,049 2021-01-01 2021-12-31 2021 FY 10-K/A 2023-04-28 0001437749-23-011640
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 42,000 2026-04-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001193125-26-336783
us-gaap StockRedeemedOrCalledDuringPeriodShares Stock Redeemed or Called During Period, Shares shares 11.50M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-22 0001493152-21-029551
us-gaap TangibleAssetImpairmentCharges Tangible Asset Impairment Charges USD 5.00M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-22 0001493152-21-029551
us-gaap TemporaryEquityAccretionToRedemptionValue Temporary Equity, Accretion to Redemption Value USD 12.52M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-22 0001493152-21-029551
us-gaap TemporaryEquityAccretionToRedemptionValueAdjustment Temporary Equity, Accretion to Redemption Value, Adjustment USD 3,635 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-09 0001493152-21-019063
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 116.15M 2021-09-30 2021 Q3 10-Q 2021-11-22 0001493152-21-029551
us-gaap TemporaryEquityRedemptionPricePerShare Temporary Equity, Redemption Price Per Share USD/shares 10.1 2021-09-30 2021 Q3 10-Q 2021-11-22 0001493152-21-029551
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 10.12M 2021-06-30 2021 Q2 10-Q 2021-08-09 0001493152-21-019063
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 11.50M 2021-09-30 2021 Q3 10-Q 2021-11-22 0001493152-21-029551
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 54,665 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap TreasuryStockShares Treasury Stock, Shares shares 546,658 2022-12-31 2022 FY 10-K 2023-04-14 0001437749-23-010343
us-gaap TreasuryStockValue Treasury Stock, Value USD 5.52M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic Undistributed Earnings (Loss) Allocated to Participating Securities, Basic USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued Unrecognized Tax Benefits, Income Tax Penalties Accrued USD 0 2021-09-30 2021 Q3 10-Q 2021-11-22 0001493152-21-029551
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-29 0000950170-22-004935
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 4.00M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-12 0001193125-26-218195
us-gaap VariableLeaseCost Variable Lease, Cost USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001833214-26-000003
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 75.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 27.34M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-29 0000950170-22-004935
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 75.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448600

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →